Efficacy and Safety of Topical Cyclosporine 0.05% and Lifitgrast on the Ocular Surface Symptom After Photorefractive Keratectomy in Feiz Hospital, Isfahan, 2024

NCT06624384 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Ocular Surface Symptom
Ocular Surface Disease
Eye Pain
Eye Inflammation

Interventions

DRUG: Group 1 drug
DRUG: Group 2: Drug and placebo
DRUG: Group 3: Drug and palcebo

Sponsor

Mohsen Pourazizi